{
  "ticker": "HALO",
  "company_name": "Halozyme Therapeutics, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT02667223",
      "title": "Pharmacokinetic and Pharmacodynamic Study of Bococizumab Alone and When Combined With Recombinant Human Hyaluronidase",
      "status": "TERMINATED",
      "phase": "PHASE1",
      "condition": "Healthy, Hypercholesterolemia",
      "start_date": "2016-02",
      "completion_date": "2016-07",
      "enrollment": 0,
      "sponsor": "Pfizer"
    },
    {
      "nct_id": "NCT06689085",
      "title": "52 Week Study of Safety, PK, & Efficacy of XYOSTED\u00ae for Testosterone Replacement in Male Adolescents With Hypogonadism",
      "status": "RECRUITING",
      "phase": "PHASE3",
      "condition": "Hypogonadism, Male",
      "start_date": "2025-02-05",
      "completion_date": "2027-12",
      "enrollment": 0,
      "sponsor": "Halozyme Therapeutics"
    },
    {
      "nct_id": "NCT01275131",
      "title": "Randomized, Double-blind, Crossover, Pharmacokinetic (PK) and Glucodynamic (GD) Study of Continuous Subcutaneous Insulin Infusion (CSII) in Participants With Type 1 Diabetes Mellitus (T1DM)",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Type 1 Diabetes Mellitus",
      "start_date": "2011-01",
      "completion_date": "2011-12",
      "enrollment": 0,
      "sponsor": "Halozyme Therapeutics"
    },
    {
      "nct_id": "NCT00979875",
      "title": "A Pharmacokinetic and Glucodynamic Study of Subcutaneously Administered Insulin Analogs With rHuPH20 Compared to Insulin Analogs Alone",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy",
      "start_date": "2009-09",
      "completion_date": "2010-05",
      "enrollment": 0,
      "sponsor": "Halozyme Therapeutics"
    },
    {
      "nct_id": "NCT01839487",
      "title": "PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Metastatic Pancreatic Cancer",
      "start_date": "2013-05-14",
      "completion_date": "2018-09-26",
      "enrollment": 0,
      "sponsor": "Halozyme Therapeutics"
    },
    {
      "nct_id": "NCT01959139",
      "title": "S1313, PEGPH20 in Treating Patients With Newly Diagnosed Metastatic Pancreatic Cancer",
      "status": "COMPLETED",
      "phase": "PHASE1, PHASE2",
      "condition": "Metastatic Pancreatic Adenocarcinoma",
      "start_date": "2014-01-23",
      "completion_date": "2023-11-09",
      "enrollment": 0,
      "sponsor": "SWOG Cancer Research Network"
    },
    {
      "nct_id": "NCT03979066",
      "title": "Study Evaluating NEOadjuvant Immunotherapy in Resectable PANCreatic Ductal Adenocarcinoma",
      "status": "TERMINATED",
      "phase": "PHASE2",
      "condition": "Pancreatic Ductal Adenocarcinoma",
      "start_date": "2019-11-01",
      "completion_date": "2019-11-03",
      "enrollment": 0,
      "sponsor": "Gulam Manji"
    },
    {
      "nct_id": "NCT00435604",
      "title": "A Study of the Subcutaneous Injection of a Viscous Antibody Solution With Recombinant Human Hyaluronidase",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy",
      "start_date": "2007-02",
      "completion_date": "2007-05",
      "enrollment": 0,
      "sponsor": "Halozyme Therapeutics"
    },
    {
      "nct_id": "NCT00369187",
      "title": "Study of a Large Protein Molecule Administered With Escalating Doses of Recombinant Human Hyaluronidase",
      "status": "COMPLETED",
      "phase": "PHASE4",
      "condition": "Rheumatoid Arthritis",
      "start_date": "2006-07",
      "completion_date": "2006-10",
      "enrollment": 0,
      "sponsor": "Halozyme Therapeutics"
    },
    {
      "nct_id": "NCT03267940",
      "title": "Study of PEGPH20 With Cisplatin (CIS) and Gemcitabine (GEM); PEGPH20 With Atezolizumab (ATEZO), CIS, and GEM; and CIS and GEM Alone in Participants With Previously Untreated, Unresectable, Locally Advanced, or Metastatic Intrahepatic and Extrahepatic Cholangiocarcinoma and Gallbladder Adenocarcinoma",
      "status": "TERMINATED",
      "phase": "PHASE1",
      "condition": "Cholangiocarcinoma Non-resectable, Cholangiocarcinoma, Intrahepatic, Cholangiocarcinoma, Extrahepatic, Gallbladder Adenocarcinoma",
      "start_date": "2017-10-02",
      "completion_date": "2019-11-11",
      "enrollment": 0,
      "sponsor": "Halozyme Therapeutics"
    }
  ],
  "summary": {
    "total_trials": 47,
    "by_phase": {
      "PHASE1": 16,
      "PHASE3": 3,
      "PHASE2": 11,
      "PHASE1, PHASE2": 5,
      "PHASE4": 11,
      "NA": 1
    },
    "by_status": {
      "TERMINATED": 7,
      "RECRUITING": 1,
      "COMPLETED": 35,
      "ACTIVE_NOT_RECRUITING": 1,
      "UNKNOWN": 1,
      "WITHDRAWN": 2
    },
    "active_trials": 2,
    "completed_trials": 35,
    "conditions": [
      "Bladder Cancer",
      "Cholangiocarcinoma Non-resectable, Cholangiocarcinoma, Intrahepatic, Cholangiocarcinoma, Extrahepatic, Gallbladder Adenocarcinoma",
      "Dehydration",
      "Dermatitis, Allergic Contact",
      "Diabetes Mellitus",
      "Diabetes Mellitus, Type 1",
      "Diabetes Mellitus, Type 2",
      "Diabetes Mellitus, Type II",
      "Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma",
      "Healthy",
      "Healthy Volunteers",
      "Healthy, Hypercholesterolemia",
      "Hereditary Angioedema",
      "Hypogonadism, Male",
      "Metastatic Breast Cancer",
      "Metastatic Pancreatic Adenocarcinoma",
      "Metastatic Pancreatic Cancer",
      "NSCLC, Gastric Cancer",
      "Non-small Cell Lung Cancer",
      "Pain",
      "Pancreatic Cancer, Advanced Pancreatic Ductal Adenocarcinoma",
      "Pancreatic Ductal Adenocarcinoma",
      "Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Pancreatic Neoplasms",
      "Pancreatic Ductal Carcinoma",
      "Rheumatoid Arthritis",
      "Risk Factors for or a Diagnosis of Osteoporosis",
      "Solid Tumor",
      "Stage IV Pancreatic Cancer",
      "Superficial Bladder Cancer",
      "Type 1 Diabetes Mellitus"
    ],
    "lead_stage": "commercial"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:18:47.382082",
    "search_query": "Halozyme Therapeutics, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Halozyme+Therapeutics,+Inc."
  }
}